Updated Jul 16, 2026
KUMAR AMIT has filed 2 SEC Form 4 filings across 1 company in the last 90 days — buying. Lifetime open-market purchases: $128K. Historical track record: 2/5 stars across 3 tracked purchases.
Amit Kumar is the Chief Executive Officer of Anixa Biosciences Inc, a biotechnology company focused on developing vaccines and therapies for cancer treatment. He has been involved in multiple SEC filings related to the company's operations.
| Role | Chief Executive Officer, Director |
|---|---|
| Notability | 30/100 |
InsiderAlpha computes a forward-return-based score for every insider with enough Form 4 purchase history. The metrics below reflect realised performance after each tracked open-market purchase.
| InsiderAlpha rating | ★★☆☆☆ (2/5) |
|---|---|
| Total purchases tracked | 3 |
| Purchases with forward-return data | 3 |
| 30-day win rate | 3333% |
| 90-day win rate | 10000% |
| Avg 5-day return | +1067.82% |
| Avg 30-day return | +110.15% |
| Avg 90-day return | +3387.26% |
| Best 30-day return | +1505.38% |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-07-13 | ANIX | Anixa Biosciences Inc | P — Open-market purchase | 5.0K | $3.04 | $15K |
| 2026-06-16 | ANIX | Anixa Biosciences Inc | P — Open-market purchase | 21.0K | $2.50 | $52K |
| 2025-10-31 | ANIX | Anixa Biosciences Inc | F — Tax withholding / forfeiture | 169.4K | $4.06 | $688K |
| 2025-10-31 | ANIX | Anixa Biosciences Inc | M — Option exercise | 200.0K | $2.92 | $584K |
| 2025-07-30 | ANIX | Anixa Biosciences Inc | P — Open-market purchase | 5.0K | $3.16 | $16K |
| 2025-07-11 | ANIX | Anixa Biosciences Inc | P — Open-market purchase | 5.0K | $3.15 | $16K |
| 2025-06-04 | ANIX | Anixa Biosciences Inc | P — Open-market purchase | 10.0K | $2.85 | $28K |
Amit Kumar is the Chief Executive Officer of Anixa Biosciences Inc, a biotechnology company focused on developing vaccines and therapies for cancer treatment. He has been involved in multiple SEC filings related to the company's operations.…
2 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 5 open-market purchases ($128K) and 0 open-market sales () across all tracked filings.
Across 3 tracked purchases, KUMAR AMIT averaged +110.2% avg 30-day return with a 3333% 30-day win rate. InsiderAlpha rates the track record at 2/5 stars.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live KUMAR AMIT profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.